Friday’s Vital Data: Bristol-Myers Squibb, Intel and Activision Blizzard
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Options trading was buzzi.....»»
Friday’s Top Analyst Upgrades and Downgrades: Bristol Myers Squibb, Carrier, Comcast, DraftKings, Nvidia, Textron and More
Friday's top analyst upgrades and downgrades included AvalonBay Communities, Bristol-Myers Squibb, Carrier, Comcast, CyrusOne, DraftKings, Nvidia and Textron......»»
3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Friday.....»»
Benzinga Pro"s Top 5 Stocks To Watch For Mon., May 4, 2020: DIS, BMY, PTON, QTNT, TBIO
Today's 5 Stock Ideas: Disney (DIS) - An earnings play. Will report quarterly results after the close on Tuesday, May 5, 2020. Bristol Myers Squibb (BMY) - A play on upcoming data related to read more.....»»
Bristol-Myers wins $752 million in U.S. patent case against Gilead
Bristol-Myers Squibb Co on Friday said it won a $752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer......»»
FTC makes Celgene"s Otezla divestiture official condition for Bristol-Myers acquisition
Celgene Corp. is required to divest its most popular psoriasis treatment in order to be acquired by Bristol-Myers Squibb Co. , the Federal Trade Commission announced Friday. For Br.....»»
Bristol-Myers Squibb wins antitrust approval to buy Celgene, but must divest psoriasis drug
Bristol-Myers Squibb Co and Celgene Corp have won U.S. antitrust approval for their merger on condition that they sell Celgene's psoriasis drug Otezla, the Federal Trade Commission said in a statement on Friday......»»
Friday’s Vital Data: Disney, Activision Blizzard and Roku
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Options tr.....»»
Fly Intel: What to watch in Bristol-Myers Squibb earnings report
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Thursday’s Vital Data: Roku, Intel, and Activision
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Options trading was buzzing in Roku, I.....»»
Wednesday’s Vital Data: Barrick Gold, Activision Blizzard and Roku
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Options trading was .....»»
Friday’s Vital Data: Zynga, Activision Blizzard and Square
InvestorPlace - Stock Market News, Stock Advice & Trading Tips.....»»
Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More
The top analyst upgrades, downgrades and initiations seen on Friday included American Express, Bristol-Myers Squibb, Celgene, CognizantTechnology Solutions, Electronic Arts, Fortinet, Lyft, Target,........»»
Bristol-Myers says shareholders vote to approve Celgene takeover
Bristol-Myers Squibb Co's shareholders voted to approve the drugmaker's $74 billion takeover of biotech Celgene Corp on Friday despite a campaign by activist hedge fund Starboard Value LP to scuttle the deal......»»
Starboard no longer urging investors to vote against Bristol-Celgene deal
Activist hedge fund Starboard Value LP said on Friday it will no longer urge shareholders to oppose Bristol-Myers Squibb Co's plans to buy Celgene Corp, even though it thinks the deal is too risky and will vote its own shares against it......»»
Proxy advisor ISS backs Bristol-Myers takeover of Celgene
Proxy advisory firm Institutional Shareholder Services on Friday recommended that shareholders of drugmaker Bristol-Myers Squibb Co vote in favor of its proposed $74 billion takeover of rival Celgene Corp......»»
Proxy advisor ISS backs Bristol takeover of Celgene
Proxy advisory firm Institutional Shareholder Services on Friday recommended shareholders of drugmaker Bristol-Myers Squibb Co shareholders vote in favor of its proposed $74 billion takeover of rival Celgene Corp......»»
Merck Cements Lead in Lung Cancer as Bristol-Myers Fizzles
Merck & Co. might have just shut the door on rival Bristol-Myers Squibb Co. as investors weigh new data that could reshape the treatment of lung cancer, by far the deadliest form of cancer in the U.S......»»
Bristol-Myers Reports Positive Data in NSCLC Trial on Opdivo
Bristol-Myers Squibb Company (BMY) announced positive results from the phase III trial, CheckMate -0.....»»
Illumina shares advance on Bristol-Myers cancer drug collaboration
Illumina Inc. shares rose in the extended session Friday after the DNA sequencing company and Bristol-Myers Squibb Co. announced they'll use Illumina's next-generation sequencing technology to develop cancer drugs at Bri.....»»
We just got a lot of updates on the state of cancer treatments — here are the winners and losers (BLUE, NKTR, LOXO, MRK, BMY)
Over the weekend at the American Society of Clinical Oncologists meeting, a lot of updates and new data were presented. It sent stocks all over the place Monday with the biggest movers being Bristol-Myers Squibb, Nektar, Loxo and Bluebird bi.....»»